Rheumatic heart disease severity, progression and outcomes

A multi-state model

Jeffrey Cannon, Kathryn Roberts, Catherine Milne, Jonathan R. Carapetis

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Rheumatic heart disease (RHD) remains a disease of international importance, yet little has been published about disease progression in a contemporary patient cohort. Multi-state models provide a well-established method of estimating rates of transition between disease states, and can be used to evaluate the cost-effectiveness of potential interventions. We aimed to create a multi-state model for RHD progression using serial clinical data from a cohort of Australian patients. 

Methods and Results: The Northern Territory RHD register was used to identify all Indigenous residents diagnosed with RHD between the ages of 5 and 24 years in the time period 1999-2012. Disease severity over time, surgeries, and deaths were evaluated for 591 patients. Of 96 (16.2%) patients with severe RHD at diagnosis, 50% had proceeded to valve surgery by 2 years, and 10% were dead within 6 years. Of those diagnosed with moderate RHD, there was a similar chance of disease regression or progression over time. Patients with mild RHD at diagnosis were the most stable, with 64% remaining mild after 10 years; however, 11.4% progressed to severe RHD and half of these required surgery. 

Conclusions: The prognosis of young Indigenous Australians diagnosed with severe RHD is bleak; interventions must focus on earlier detection and treatment if the observed natural history is to be improved. This multi-state model can be used to predict the effect of different interventions on disease progression and the associated costs.

Original languageEnglish
Article numbere003498
Number of pages16
JournalJournal of the American Heart Association
Volume6
Issue number3
DOIs
Publication statusPublished - Mar 2017

Fingerprint

Rheumatic Heart Disease
Disease Progression
Northern Territory
Natural History
Cost-Benefit Analysis
Costs and Cost Analysis

Cite this

Cannon, Jeffrey ; Roberts, Kathryn ; Milne, Catherine ; Carapetis, Jonathan R. / Rheumatic heart disease severity, progression and outcomes : A multi-state model. In: Journal of the American Heart Association. 2017 ; Vol. 6, No. 3.
@article{163d1f47c7084777982f0a02cc5e06e7,
title = "Rheumatic heart disease severity, progression and outcomes: A multi-state model",
abstract = "Background: Rheumatic heart disease (RHD) remains a disease of international importance, yet little has been published about disease progression in a contemporary patient cohort. Multi-state models provide a well-established method of estimating rates of transition between disease states, and can be used to evaluate the cost-effectiveness of potential interventions. We aimed to create a multi-state model for RHD progression using serial clinical data from a cohort of Australian patients. Methods and Results: The Northern Territory RHD register was used to identify all Indigenous residents diagnosed with RHD between the ages of 5 and 24 years in the time period 1999-2012. Disease severity over time, surgeries, and deaths were evaluated for 591 patients. Of 96 (16.2{\%}) patients with severe RHD at diagnosis, 50{\%} had proceeded to valve surgery by 2 years, and 10{\%} were dead within 6 years. Of those diagnosed with moderate RHD, there was a similar chance of disease regression or progression over time. Patients with mild RHD at diagnosis were the most stable, with 64{\%} remaining mild after 10 years; however, 11.4{\%} progressed to severe RHD and half of these required surgery. Conclusions: The prognosis of young Indigenous Australians diagnosed with severe RHD is bleak; interventions must focus on earlier detection and treatment if the observed natural history is to be improved. This multi-state model can be used to predict the effect of different interventions on disease progression and the associated costs.",
keywords = "Pediatric, Prognosis, Rheumatic heart disease",
author = "Jeffrey Cannon and Kathryn Roberts and Catherine Milne and Carapetis, {Jonathan R.}",
year = "2017",
month = "3",
doi = "10.1161/JAHA.116.003498",
language = "English",
volume = "6",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "3",

}

Rheumatic heart disease severity, progression and outcomes : A multi-state model. / Cannon, Jeffrey; Roberts, Kathryn; Milne, Catherine; Carapetis, Jonathan R.

In: Journal of the American Heart Association, Vol. 6, No. 3, e003498, 03.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Rheumatic heart disease severity, progression and outcomes

T2 - A multi-state model

AU - Cannon, Jeffrey

AU - Roberts, Kathryn

AU - Milne, Catherine

AU - Carapetis, Jonathan R.

PY - 2017/3

Y1 - 2017/3

N2 - Background: Rheumatic heart disease (RHD) remains a disease of international importance, yet little has been published about disease progression in a contemporary patient cohort. Multi-state models provide a well-established method of estimating rates of transition between disease states, and can be used to evaluate the cost-effectiveness of potential interventions. We aimed to create a multi-state model for RHD progression using serial clinical data from a cohort of Australian patients. Methods and Results: The Northern Territory RHD register was used to identify all Indigenous residents diagnosed with RHD between the ages of 5 and 24 years in the time period 1999-2012. Disease severity over time, surgeries, and deaths were evaluated for 591 patients. Of 96 (16.2%) patients with severe RHD at diagnosis, 50% had proceeded to valve surgery by 2 years, and 10% were dead within 6 years. Of those diagnosed with moderate RHD, there was a similar chance of disease regression or progression over time. Patients with mild RHD at diagnosis were the most stable, with 64% remaining mild after 10 years; however, 11.4% progressed to severe RHD and half of these required surgery. Conclusions: The prognosis of young Indigenous Australians diagnosed with severe RHD is bleak; interventions must focus on earlier detection and treatment if the observed natural history is to be improved. This multi-state model can be used to predict the effect of different interventions on disease progression and the associated costs.

AB - Background: Rheumatic heart disease (RHD) remains a disease of international importance, yet little has been published about disease progression in a contemporary patient cohort. Multi-state models provide a well-established method of estimating rates of transition between disease states, and can be used to evaluate the cost-effectiveness of potential interventions. We aimed to create a multi-state model for RHD progression using serial clinical data from a cohort of Australian patients. Methods and Results: The Northern Territory RHD register was used to identify all Indigenous residents diagnosed with RHD between the ages of 5 and 24 years in the time period 1999-2012. Disease severity over time, surgeries, and deaths were evaluated for 591 patients. Of 96 (16.2%) patients with severe RHD at diagnosis, 50% had proceeded to valve surgery by 2 years, and 10% were dead within 6 years. Of those diagnosed with moderate RHD, there was a similar chance of disease regression or progression over time. Patients with mild RHD at diagnosis were the most stable, with 64% remaining mild after 10 years; however, 11.4% progressed to severe RHD and half of these required surgery. Conclusions: The prognosis of young Indigenous Australians diagnosed with severe RHD is bleak; interventions must focus on earlier detection and treatment if the observed natural history is to be improved. This multi-state model can be used to predict the effect of different interventions on disease progression and the associated costs.

KW - Pediatric

KW - Prognosis

KW - Rheumatic heart disease

UR - http://www.scopus.com/inward/record.url?scp=85015024500&partnerID=8YFLogxK

U2 - 10.1161/JAHA.116.003498

DO - 10.1161/JAHA.116.003498

M3 - Article

VL - 6

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 3

M1 - e003498

ER -